{
    "wpid": "WP262",
    "organisms": ["Homo sapiens"],
    "description": "Latent membrane protein 1 (LMP1) of the Ebstein-Barr Virus (EBV) elicits its oncogenice effects through the activation of several downstream pathways suchs as Pi3K/akt, IRF4, and NFkB pathways.  Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP262 CPTAC Assay Portal]",
    "ontology-ids": [
        "PW:0001057",
        "PW:0001059"
    ],
    "last-edited": "20210509",
    "title": "Ebstein-Barr virus LMP1 signaling",
    "authors": ["Thomas","MartijnVanIersel","MaintBot","Khanspers","Christine Chichester","AlexanderPico","Zari","Mkutmon","Roelod","Eweitz"],
    "revision": "r116630"
}